Sort   by:  
 Page size 
UnknownThe landscape of reported VUS in multi-gene panel and genomic testing: Time for a change.
Not available
S-EPMC10825061 | biostudies-literature
UnknownWhole genome sequence analyses of eGFR in 23,732 people representing multiple ancestries in the NHLBI trans-omics for precision medicine (TOPMed) consortium.
Not available
S-EPMC7804602 | biostudies-literature
UnknownWhole genome sequence association analysis of fasting glucose and fasting insulin levels in diverse cohorts from the NHLBI TOPMed program.
Not available
S-EPMC9334637 | biostudies-literature
UnknownWHOLE GENOME SEQUENCING ANALYSIS OF BODY MASS INDEX IDENTIFIES NOVEL AFRICAN ANCESTRY-SPECIFIC RISK ALLELE.
Not available
S-EPMC10473809 | biostudies-literature
UnknownRandomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALS.
Not available
S-EPMC4396529 | biostudies-literature
UnknownWhole genome sequencing analysis of body mass index identifies novel African ancestry-specific risk allele.
Not available
S-EPMC11992084 | biostudies-literature
UnknownSame data, different analysts: variation in effect sizes due to analytical decisions in ecology and evolutionary biology.
Not available
S-EPMC11804095 | biostudies-literature
UnknownCirculating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program.
Not available
S-EPMC4158711 | biostudies-literature
UnknownConfirming glycemic status in the Diabetes Prevention Program: implications for diagnosing diabetes in high risk adults.
Not available
S-EPMC3594066 | biostudies-literature
UnknownCommon variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program.
Not available
S-EPMC4154629 | biostudies-literature
Sort   by:  
 Page size